Connect with us

Hi, what are you looking for?

Stock

AMD, J&J lead market cap stock movers on Wednesday

Wednesday’s trading session has showcased a variety of fluctuations among stocks, particularly within the mega-cap and large-cap sectors. Investors have been reactive to news and market shifts, resulting in notable intra-day stock movements. Mega-cap stocks such as Adv Micro Device (NASDAQ:AMD) and Johnson & Johnson (NYSE:JNJ) have experienced declines, while in the large-cap category, Ebay Inc (NASDAQ:EBAY) has seen a surge. Here’s an overview of some of the key stock movers across different market capitalization categories today.

Mega-Cap Movers (Market Cap $200B+)

  • Johnson & Johnson (JNJ); J&J gains FDA Fast Track for Alzheimer’s treatments: -3.01%
  • Exxon Mobil (NYSE:XOM): -2.48%
  • Adv Micro Device (AMD): -4.49%

Large-Cap Stock Movers (Market Cap $10B-$200B)

  • dMY Technology Group III (IONQ): -39.6%
  • Mobileye Global (NASDAQ:MBLY): -14.88%
  • Edison Intl (NYSE:EIX): -13.31%
  • Ebay Inc (EBAY): +9.3%
  • Moderna (NASDAQ:MRNA): -8.48%
  • Reinvent Technology Partners Y (AUR): -7.76%
  • Roku (NASDAQ:ROKU): +6.5%
  • ON Semiconductor (NASDAQ:ON): -7.11%
  • Xpeng Inc (NYSE:XPEV): -5.44%
  • FBTC NYSE (FBTC): -2.29%

Mid-Cap Stock Movers (Market Cap $2B-$10B)

  • Rigetti Computing Inc (NASDAQ:RGTI): -44.33%
  • Quantum (NASDAQ:QMCO) Computing OTC (QUBT); Quantum Computing, Inc. Announces Private Placement of Common Stock for Proceeds of $100 Million: -41.03%
  • DPCM Capital (QBTS): -34.14%
  • CF Acquisition Corp VI (RUMBW): -21.05%
  • SoundHound AI (NASDAQ:SOUN): -16.5%
  • Catalyst Pharmaceuticals (NASDAQ:CPRX); Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Teva Pharmaceuticals: +13.19%
  • Rumble (RUM): -13.16%
  • AltC Acquisition (OKLO): -12.1%
  • Nuscale Power (SMR): -12.37%
  • Plug Power (NASDAQ:PLUG): -11.06%

Small-Cap Stock Movers (Market Cap $300M-$2B)

  • Sana Biotechnology (SANA); Sana reports success in diabetes cell therapy without immunosuppression: +201.82%
  • Vir Biotechnology Inc (NASDAQ:VIR); Vir Biotechnology Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for Dual Masked T-Cell Engagers VIR-5818 in Solid Tumors and VIR-5500 in mCRPC: +64.05%
  • Avita Medical Ltd (NASDAQ:RCEL); AVITA Medical (TASE:PMCN) Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial Guidance: -36.98%
  • AngioDynamics (NASDAQ:ANGO); AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results: +29.68%
  • Atomera Inc (ATOM): -27.16%
  • Centricus Acquisition (ARQQ): -25.25%
  • HighCape Capital Acquisition (QSI); Quantum-Si’s New Preprint Showcases Protein Barcoding as a Powerful Tool for Transforming Proteomics: -23.34%
  • CMI Acquisition LLC (SKYT): -20.45%
  • MSTU (MSTU): -5.35%
  • Armada Acquisition I (RZLV): -20.03%

For real-time, market-moving news, join Investing Pro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com

You May Also Like

Editor's Pick

Adani Group shares experienced a rebound on Monday, recovering from last week’s steep losses sparked by U.S. criminal charges against Chairman Gautam Adani and...

Economy

By Leika Kihara TOKYO (Reuters) -Some Bank of Japan policymakers saw conditions falling into place for an imminent rate hike with one predicting a...

Latest News

The Department of Defense (DoD) announced two weapons packages for Ukraine on Monday, totaling $2.47 billion. The first of the two, the Presidential Drawdown...

Latest News

It was former President Obama who famously quipped that ‘elections have consequences,’ and one of the consequences of the 2024 election is that President-elect...



Disclaimer: Techreportdiversity.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2024 Techreportdiversity.com